Loss of GLS was confirmed by qRT-PCR and Western blot analysis in isolated lung microvascular ECs (Fig. 1B), as well as colocalization of anti-GLS and anti-CD31 immunofluorescence in tumor sections (Fig. 1C). This evidence concerns the gene GLS and neoplasm.